Cargando…
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo
BACKGROUND: Previous studies demonstrate that tolterodine extended release (ER) significantly improves urgency urinary incontinence (UUI) episodes. Instruments that measure patient-reported outcomes (PROs) provide additional information that is valuable for assessing whether clinical improvements ar...
Autores principales: | Van Kerrebroeck, Philip EV, Kelleher, Con J, Coyne, Karin S, Kopp, Zoe, Brodsky, Marina, Wang, Joseph T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649907/ https://www.ncbi.nlm.nih.gov/pubmed/19226471 http://dx.doi.org/10.1186/1477-7525-7-13 |
Ejemplares similares
-
Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009) -
Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013) -
Fesoterodine for the treatment of urinary incontinence and overactive bladder
por: Ellsworth, Pamela
Publicado: (2009) -
Understanding overactive bladder and urgency incontinence: what does the brain have to do with it?
por: Smith, Ariana L.
Publicado: (2018) -
Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)